Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7062
Source ID: NCT01417897
Associated Drug: Insulin Glulisine
Title: Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study
Acronym: HERMES
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Insulin glulisine|DRUG: Insulin aspart|DRUG: Regular human insulin
Outcome Measures: Primary: Nitrotyrosine, The difference in the percent increase of the oxidative stress biomarker nitrotyrosine after stimulation with a standardized meal, Baseline, after 10 weeks, after 24 weeks | Secondary: Skin blood flow, Change in skin blood flow during stimulation by a standardized meal, Baseline, after 10 weeks, after 24 weeks|mRNA expression of proinflammatory cytokines (MAPK/eNOS, adiponectin, hsCRP, MMP-9), Biomarkers of sub-clinical inflammation and cardiovascular risk: Change in Macrophage activation, MAPK/eNOS production levels, adiponectin and hsCRP (after test meal) from baseline to endpoint, Baseline, after 10 weeks, after 24 weeks|Insulin, Change in Insulin and the ratio from baseline to endpoint, Baseline, after 10 weeks, after 24 weeks|HbA1c, Blood glucose control: Change during test meal, HbA1c and FBG from baseline to endpoint, Baseline, after 10 weeks, after 24 weeks|Fasting blood glucose, Blood glucose control: Change during test meal, HbA1c and FBG from baseline to endpoint, Baseline, after 10 weeks, after 24 weeks|Hypoglycemic events, Incidence of hypoglycemia from baseline to endpoint, Baseline, after 10 weeks, after 24 weeks|intact Proinsulin, Change in intact Proinsulin and the ratio from baseline to endpoint, Baseline, after 10 weeks, after 24 weeks
Sponsor/Collaborators: Sponsor: ikfe-CRO GmbH | Collaborators: IKFE Institute for Clinical Research and Development
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 12
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2011-09
Completion Date: 2012-05
Results First Posted:
Last Update Posted: 2012-03-05
Locations: ife GmbH, Clinic, Mainz, Rhineland-Palatinate, 55116, Germany
URL: https://clinicaltrials.gov/show/NCT01417897